AU2022267109A1 - Composition for increasing red blood cells and/or hemoglobin - Google Patents

Composition for increasing red blood cells and/or hemoglobin Download PDF

Info

Publication number
AU2022267109A1
AU2022267109A1 AU2022267109A AU2022267109A AU2022267109A1 AU 2022267109 A1 AU2022267109 A1 AU 2022267109A1 AU 2022267109 A AU2022267109 A AU 2022267109A AU 2022267109 A AU2022267109 A AU 2022267109A AU 2022267109 A1 AU2022267109 A1 AU 2022267109A1
Authority
AU
Australia
Prior art keywords
composition
ergothioneine
salt
present
red blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022267109A
Other languages
English (en)
Inventor
Makoto Katsube
Norihito Murayama
Hiroshi Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of AU2022267109A1 publication Critical patent/AU2022267109A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2022267109A 2021-04-26 2022-03-25 Composition for increasing red blood cells and/or hemoglobin Pending AU2022267109A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021-074320 2021-04-26
JP2021074320 2021-04-26
PCT/JP2022/014221 WO2022230487A1 (ja) 2021-04-26 2022-03-25 赤血球及び／又はヘモグロビン増加用組成物

Publications (1)

Publication Number Publication Date
AU2022267109A1 true AU2022267109A1 (en) 2023-10-12

Family

ID=83847365

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022267109A Pending AU2022267109A1 (en) 2021-04-26 2022-03-25 Composition for increasing red blood cells and/or hemoglobin

Country Status (7)

Country Link
US (1) US20240180876A1 (https=)
EP (1) EP4331580A4 (https=)
JP (1) JPWO2022230487A1 (https=)
CN (1) CN117202904A (https=)
AU (1) AU2022267109A1 (https=)
TW (1) TW202308616A (https=)
WO (1) WO2022230487A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020376265B2 (en) * 2019-10-28 2026-02-19 Suntory Holdings Limited Composition for sleep improvement comprising ergothioneine or salt thereof
WO2024038821A1 (ja) * 2022-08-17 2024-02-22 サントリーホールディングス株式会社 フレイル予防又は改善用組成物、及び、加齢に伴う身体活動能力低下を抑制又は改善するための組成物
WO2025157153A1 (zh) * 2024-01-25 2025-07-31 南京纽邦生物科技有限公司 用于增强运动表现的方法及组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020110604A1 (en) * 2000-08-11 2002-08-15 Ashni Naturaceuticals, Inc. Composition exhibiting synergistic antioxidant activity
JP5658479B2 (ja) 2009-04-27 2015-01-28 株式会社岩出菌学研究所 脂肪減少等の活性を示す組成物
CA2839244A1 (en) * 2011-06-13 2012-12-20 Entia Biosciences, Inc. A nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention of associated comorbid states with the use of ergothioneine
US20150157648A1 (en) * 2012-06-26 2015-06-11 Entia Biosciences, Inc. Nutritional approach to improving athletic performance and reducing injury with l-ergothioneine and/or vitamin d2
JP5904378B2 (ja) * 2013-02-28 2016-04-13 株式会社エル・エスコーポレーション 抗うつ剤
CN112352046A (zh) * 2018-06-29 2021-02-09 长濑产业株式会社 麦角硫因、抗坏血酸2-葡糖苷、抗坏血酸和它们的组合的成肌分化促进作用

Also Published As

Publication number Publication date
EP4331580A1 (en) 2024-03-06
EP4331580A4 (en) 2025-03-19
US20240180876A1 (en) 2024-06-06
WO2022230487A1 (ja) 2022-11-03
CN117202904A (zh) 2023-12-08
TW202308616A (zh) 2023-03-01
JPWO2022230487A1 (https=) 2022-11-03

Similar Documents

Publication Publication Date Title
US20240180876A1 (en) Composition for increasing red blood cells and/or hemoglobin
US20240173298A1 (en) Composition for ameliorating or suppressing decline of kidney functions
JP7757450B2 (ja) エルゴチオネイン又はその塩を含有する睡眠改善用組成物
US20240180877A1 (en) Anti-anxiety composition
JP7817249B2 (ja) 免疫細胞の代謝促進用組成物
TW202423421A (zh) 預防或改善衰弱用之組成物，及抑制或改善高齡所伴隨之身體活動力降低用之組成物
US20240156785A1 (en) Composition for improving blood cholesterol level
US20240189284A1 (en) Composition for promoting lipolysis
US20250017905A1 (en) Composition for inhibiting histamine-n-methyltransferase
HK40103316A (zh) 红血球及/或血红蛋白增加用组合物
CN121001582A (zh) 含有麦角硫因或其盐的用于预防、减轻或改善中暑或脱水症的组合物及用于调节细胞内外水分的组合物
WO2024172002A1 (ja) エルゴチオネインを含有する血管拡張用組成物
HK40103317A (zh) 肾功能的降低抑制或改善用组合物
WO2024172003A1 (ja) エルゴチオネインを含有する筋萎縮抑制用組成物及びＳｒｃチロシンキナーゼ阻害用組成物
HK40075030A (en) Composition for sleep improvement comprising ergothioneine or salt thereof